Association of TGFβ1 polymorphisms involved in radiation toxicity with TGFβ1 secretion in vitro

Cytokine

Volumn 50, Issue 1, 2010, Pages 37-41

  Kim, De Ruyck ^a   Laurence, Beels ^a   Jan, Van Meerbeeck ^b   Wilfried, De Neve ^b   Hubert, Thierens ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Lymphocytes; Polymorphisms; Radiation induced lung injury; Secretion; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; PATHOGENESIS; PRIORITY JOURNAL; RADIATION INJURY; SIGNAL TRANSDUCTION; WILD TYPE; GENETIC PREDISPOSITION; GENETICS; SECRETION; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RADIATION INJURIES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77049113182     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.12.013     Document Type: Article

References (36)

1. Marks L.B., Yu X.L., Vujaskovic Z., Small W., Folz R., and Anscher M.S. Radiation-induced lung injury. Semin Radiat Oncol 13 (2003) 333-345
2. Madani I., De Ruyck K., Goeminne H., De Neve W., Thierens H., and Van Meerbeeck J. Predicting risk of radiation-induced lung injury. J Thorac Oncol 2 (2007) 864-874
3. Martin M., Lefaix J.L., and Delanian S. TGFβ1 and radiation fibrosis: a master switch and a specific therapeutic agent?. Int J Radiat Oncol Biol Phys 47 (2000) 277-290
4. Anscher M.S., Kong F.M., Andrews K., Clough R., Marks L.B., Bentel G., et al. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41 (1998) 1029-1035
5. Anscher M.S., Marks L.B., Shafman T.D., Clough R., Huang H., Tisch A., et al. Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 988-995
6. Fu X.L., Huang H., Bentel G., Clough R., Jirtle R.L., Kong F.M., et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 50 (2001) 899-908
7. Zhao L., Sheldon K., Chen M., Yin M.S., Hayman J.A., Katemkerian G.P., et al. The predictive role of plasma TGFβ1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung cancer 59 (2008) 232-239
8. Chen Y., Williams J., Ding I., Hernady E., Liu W., Smudzin T., et al. Radiation pneumonitis and early circulatory cytokine markers. Sem Radiat Oncol 12 (2002) 26-33
9. De Jaeger K., Seppenwoolde Y., Kampinga H.H., Boersma L.J., Belderbos J.S.A., and Lebesque J.V. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1378-1387
10. Novakova-Jiresova A., Van Gameren M.M., Coppes R.P., Kampinga H.H., and Groen H.J.M. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol 71 (2004) 183-189
11. Hart J.P., Broadwater G., Rabbani Z., Moeller B.J., Clough R., Huang D., et al. Cytokine profiling for prediction of symptomatic radiation-induced lung injury. Int J Radiat Oncol Biol Phys 63 (2005) 1448-1454
12. Kong F.M., Anscher M.S., and Jirtle R.L. Transforming growth factor beta: a plasma tumor marker. In: Hausanek M., and Walaszek Z. (Eds). Methods in molecular biology: tumor marker protocols (1997), Human Press Inc., New Jersey 417-430
13. Quarmby S., Fakhoury H., Levine E., Barber J., Wylie J., Hajeer A.H., et al. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79 (2003) 137-143
14. Andreassen C.N., Alsner J., Overgaard M., and Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 69 (2003) 127-135
15. Andreassen C.N., Alsner J., Overgaard J., Herskind C., Haviland J., Owen R., et al. TGFβ1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiat Oncol 75 (2005) 18-21
16. De Ruyck K., Van Eijkeren M., Claes K., Bacher K., Vral A., De Neve W., et al. TGFβ1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors. Int J Radiat Oncol Biol Phys 65 (2006) 1240-1248
17. Shah R., and Rahaman B. Allelic diversity in the TGFβ1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Hum Genet 119 (2006) 61-64
18. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., et al. Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 8 (1999) 93-97
19. Meng J.F., Thongngarm T., Nakajima M., Yamashita N., Ohta K., Bates C.A., et al. Association of transforming growth factor-beta 1 single nucleotide polymorphism C-509T with allergy and immunological activities. Int Arch Allergy Immunol 138 (2005) 151-160
20. Luedecking E.K., DeKosky S.T., Mehdi H., Ganguli M., and Kamboh M.I. Analysis of genetic polymorphisms in the transforming growth factor-beta 1 gene and the risk of Alzheimer's disease. Hum Genet 106 (2000) 565-569
21. Silverman E.S., Palmer L.J., Subramaniam V., Hallock A., Mathew S., Vallone J., et al. Transforming growth factor-beta(1) promoter polymorphism C-509T is associated with asthma. Am J Resp Crit Care 169 (2004) 214-219
22. Dunning A.M., Ellis P.D., McBride S., Kirschenlohr H.L., Healey C.S., Kemp P.R., et al. A transforming growth factor β1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 63 (2003) 2610-2615
23. Yokota M., Ichihara S., Lin T.L., Nakashima N., and Yamada Y. Association of a T29 → C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101 (2000) 2783-2787
24. Yamada Y., Miyauchi A., Goto J., Takagi Y., Okuizumi H., Kanematsu M., et al. Association of a polymorphism of the transforming growth factor-beta 1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 13 (1998) 1569-1576
25. Khalil M.S., El Nahas A.M., and Blakemore A.I.F. Transforming growth factor-beta(1) SNPs: genetic and phenotypic correlations in progressive kidney insufficiency. Nephron Exp Nephrol 101 (2005) E31-E41
26. Awad M.R., El-Gamel A., Hasleton P., Turner D.M., Sinnott P.J., and Hutchinson I.V. Genotypic variation in the transforming growth factor-beta 1 gene: association with transforming growth factor-beta 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66 (1998) 1014-1020
27. Lau H.H.L., Ho A.Y.Y., Luk K.D.K., and Kung A.W.C. Transforming growth factor-beta 1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women. Calcif Tissue Int 74 (2004) 516-521
28. Carrieri G., Marzi E., Olivieri F., Marchegiani F., Cavallone L., Cardelli M., et al. The G/C-915 polymorphism of transforming growth factor beta 1 is associated with human longevity: a study in Italian centenarians. Aging Cell 3 (2004) 443-448
29. Mak J.C.W., Leung H.C.M., Sham A.S.K., Mok T.Y.W., Poon Y.N., Ling S.O., et al. Genetic polymorphisms and plasma levels of transforming growth factor-β1 in Chinese patients with tuberculosis in Hong Kong. Cytokine 40 (2007) 177-182
30. Wang H., Zhao Y., Gao C., Ji Q., Gressner A.M., Yang Z.X., et al. Transforming growth factor β1 gene variants increase transcription and are associated with liver cirrhosis in Chinese. Cytokine 43 (2008) 20-25
31. Husted L.B., Sorensen L., Stenkjaer L., Carstens M., and Langdahl B.L. The T29C polymorphism in the signal peptide of transforming growth factor beta1 increases secretion in vitro. Calcif Tissue Int 82 (2008) S141
32. Janssens K., ten Dijke P., Janssens S., and Van Hul W. Transforming growth factor-β1 to the bone. Endocr Rev 26 (2005) 743-774
33. Kim S.J., Glick A., Sporn M.B., and Roberts A.B. Characterization of the promoter region of the human transforming growth factor-β1 gene. J Biol Chem 264 (1989) 402-408
34. Pasche B., Kolachana P., Nafa K., Satagopan J., Chen Y.G., Lo R.S., et al. TβR-I(6A) is a candidate tumor susceptibility allele. Cancer Res 59 (1999) 5678-5682
35. Chen T.P., De Vries E.G.E., Hollema H., Yegen H.A., Vellucci V.F., Strickler H.D., et al. Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer 82 (1999) 43-51
36. Mohren S., and Weiskirchen R. Non-synonymous gene polymorphisms in the secretory signal peptide of human TGF-β1 affect cellular synthesis but not secretion of TGF-β1. Biochem Biophys Res Comm 379 (2009) 1015-1020